178 related articles for article (PubMed ID: 37759826)
1. Coupled Electrostatic and Hydrophobic Destabilisation of the Gelsolin-Actin Complex Enables Facile Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid.
Davoudian K; Bhattacharya S; Thompson D; Thompson M
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759826
[TBL] [Abstract][Full Text] [Related]
2. Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid.
Davoudian K; Spagnolo S; Lotay N; Satkauskas M; Mészáros G; Hianik T; Keresztes Z; Walker G; Thompson M
Biosensors (Basel); 2024 Jun; 14(6):. PubMed ID: 38920591
[TBL] [Abstract][Full Text] [Related]
3. Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid.
Meerschaert K; De Corte V; De Ville Y; Vandekerckhove J; Gettemans J
EMBO J; 1998 Oct; 17(20):5923-32. PubMed ID: 9774337
[TBL] [Abstract][Full Text] [Related]
4. Gelsolin binding and cellular presentation of lysophosphatidic acid.
Goetzl EJ; Lee H; Azuma T; Stossel TP; Turck CW; Karliner JS
J Biol Chem; 2000 May; 275(19):14573-8. PubMed ID: 10799543
[TBL] [Abstract][Full Text] [Related]
5. Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum.
De La Franier B; Thompson M
Biosensors (Basel); 2020 Feb; 10(2):. PubMed ID: 32075013
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics study of a gelsolin-derived peptide binding to a lipid bilayer containing phosphatidylinositol 4,5-bisphosphate.
Liepiņa I; Czaplewski C; Janmey P; Liwo A
Biopolymers; 2003; 71(1):49-70. PubMed ID: 12712500
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid and lipopolysaccharide bind to the PIP2-binding domain of gelsolin.
Mintzer E; Sargsyan H; Bittman R
Biochim Biophys Acta; 2006 Jan; 1758(1):85-9. PubMed ID: 16460666
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Tailoring of Electrostatic and Hydrophobic Interactions for Rapid and Specific Recognition of Lysophosphatidic Acid, an Early-Stage Ovarian Cancer Biomarker.
Wang Y; Pei H; Jia Y; Liu J; Li Z; Ai K; Lu Z; Lu L
J Am Chem Soc; 2017 Aug; 139(33):11616-11621. PubMed ID: 28782946
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics study of interactions between polymorphic actin filaments and gelsolin segment-1.
Lee M; Kang EH
Proteins; 2020 Feb; 88(2):385-392. PubMed ID: 31498927
[TBL] [Abstract][Full Text] [Related]
10. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of lysophosphatidic acid and phosphatidylinositol 4,5-bisphosphate on actin dynamics by direct association with the actin-binding protein villin.
Tomar A; George SP; Mathew S; Khurana S
J Biol Chem; 2009 Dec; 284(51):35278-82. PubMed ID: 19808673
[TBL] [Abstract][Full Text] [Related]
12. Affinity-based electrochemical biosensor with antifouling properties for detection of lysophosphatidic acid, a promising early-stage ovarian cancer biomarker.
Ahmadi S; Lotay N; Thompson M
Bioelectrochemistry; 2023 Oct; 153():108466. PubMed ID: 37244204
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Nguyen GH; French R; Radhakrishna H
Cell Signal; 2004 Oct; 16(10):1141-51. PubMed ID: 15240009
[TBL] [Abstract][Full Text] [Related]
14. Regulation of sperm motility by PIP2(4,5) and actin polymerization.
Finkelstein M; Megnagi B; Ickowicz D; Breitbart H
Dev Biol; 2013 Sep; 381(1):62-72. PubMed ID: 23791551
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the binding mechanism of LPA species and analogs in an LPA
Wang H; Li M; St Onge CM; Fuss B; Zhang Y
J Mol Graph Model; 2022 Nov; 116():108274. PubMed ID: 35868118
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer.
Meng Y; Kang S; Fishman DA
FEBS Lett; 2005 Feb; 579(5):1311-9. PubMed ID: 15710431
[TBL] [Abstract][Full Text] [Related]
17. [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].
Tanyi J; Rigó J
Orv Hetil; 2009 Jun; 150(24):1109-18. PubMed ID: 19739275
[TBL] [Abstract][Full Text] [Related]
18. Identification of a polyphosphoinositide-modulated domain in gelsolin which binds to the sides of actin filaments.
Yin HL; Iida K; Janmey PA
J Cell Biol; 1988 Mar; 106(3):805-12. PubMed ID: 2831234
[TBL] [Abstract][Full Text] [Related]
19. Polyphosphoinositide micelles and polyphosphoinositide-containing vesicles dissociate endogenous gelsolin-actin complexes and promote actin assembly from the fast-growing end of actin filaments blocked by gelsolin.
Janmey PA; Iida K; Yin HL; Stossel TP
J Biol Chem; 1987 Sep; 262(25):12228-36. PubMed ID: 3040735
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis.
Cao L; Zhang Y; Fu Z; Dong L; Yang S; Meng W; Li Y; Zhang W; Zhang J; Zheng C; Zhu H; Fan L
J Obstet Gynaecol Res; 2015 Dec; 41(12):1951-8. PubMed ID: 26472266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
